Rezultati pretraživanja
  1. 30. sij

    Pharmalot.. Pharmalittle.. Good Morning.. Drug prices to rise 3.59%, House committee considers bill to require generic drug makers to update labeling for safety & more news..

  2. 30. sij
  3. 29. sij
  4. 29. sij

    Spring Bank Pharma decision comes after patient died in phase 2 trial

  5. 26. pro 2019.

    Stops Dosing and Enrollment in All Inarigivir Studies in Subjects With Chronic HBV

  6. 7. stu 2019.
  7. 17. lis 2019.

    depressingly boring HBV data: RNAi agents by far most exciting class currently under development.

  8. 2. ruj 2019.

    A great review from on advances in therapies for and the path towards a cure: Relevant companies:

  9. 27. kol 2019.

    Excellent new review on therapeutic strategies for infection Very timely for deal today. Hopefully innovation will help solve this major global public health problem soon like we did with !

  10. 19. velj 2019.

    Appoints Atif Abbas as Head of Oncology & Immunology Clinical Development

  11. 10. ožu 2017.

    Significant Progress in 2016; Expect Initial ACHIEVE Readouts 1H:17

  12. 11. stu 2016.

    Compelling Data shown in Pre-Clinical Models

  13. 21. lis 2016.
  14. 18. ruj 2016.

    It's a personal fight: Phase 2a trials for chronic HBV -

  15. 2. svi 2016.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.